BUONTEMPO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 304
EU - Europa 80
AS - Asia 16
AF - Africa 3
SA - Sud America 1
Totale 404
Nazione #
US - Stati Uniti d'America 302
IT - Italia 27
DE - Germania 17
GB - Regno Unito 11
IE - Irlanda 6
SE - Svezia 5
CN - Cina 3
IN - India 3
KR - Corea 3
ZA - Sudafrica 3
CA - Canada 2
CZ - Repubblica Ceca 2
FR - Francia 2
IR - Iran 2
RU - Federazione Russa 2
TR - Turchia 2
AM - Armenia 1
BE - Belgio 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
JP - Giappone 1
LU - Lussemburgo 1
MK - Macedonia 1
NL - Olanda 1
PL - Polonia 1
TW - Taiwan 1
Totale 404
Città #
Santa Cruz 44
Fairfield 24
Ashburn 16
Buffalo 14
Bologna 11
Seattle 10
Boardman 9
Southend 8
Wilmington 8
Cambridge 6
Fleming Island 6
Stockholm 5
Woodbridge 5
Bremen 4
Chicago 4
Clearwater 4
Dublin 4
Houston 4
San Diego 4
Fennville 3
Frankfurt Am Main 3
Henderson 3
Mountain View 3
Muizenberg 3
Notre Dame 3
Ann Arbor 2
Beijing 2
Galway 2
Gaziantep 2
Herndon 2
Los Angeles 2
New York 2
Provo 2
Rome 2
Seoul 2
Vancouver 2
Villa Lagarina 2
Ancona 1
Andover 1
Auburn 1
Bellevue 1
Bengaluru 1
Berlin 1
Bitola 1
Cerro Maggiore 1
Cesena 1
Columbus 1
Council Bluffs 1
Daegu 1
Dallas 1
Duncan 1
Hershey 1
Hesperange 1
Kashan 1
Köln 1
Lake Forest 1
Leuven 1
Lublin 1
Milton Keynes 1
Nagold 1
New Orleans 1
Ottawa 1
Phoenix 1
Portland 1
Princeton 1
Redmond 1
Rimini 1
San Francisco 1
Scranton 1
Silver Spring 1
Stanford 1
Tamm 1
Tokyo 1
Vaciamadrid 1
Yerevan 1
Totale 270
Nome #
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device, file e1dcb333-8e87-7715-e053-1705fe0a6cc9 70
Therapeutic targeting of CK2 in acute and chronic leukemias., file e1dcb338-83af-7715-e053-1705fe0a6cc9 69
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway., file e1dcb335-574f-7715-e053-1705fe0a6cc9 53
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia, file e1dcb338-3743-7715-e053-1705fe0a6cc9 52
Protective effect of different antioxidant agents in UVB-irradiated keratinocytes, file e1dcb330-5c68-7715-e053-1705fe0a6cc9 48
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB., file e1dcb338-5bfa-7715-e053-1705fe0a6cc9 45
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors., file e1dcb337-549d-7715-e053-1705fe0a6cc9 32
Marine bisindole alkaloid: a potential apoptotic inducer in cancer cells., file e1dcb335-2130-7715-e053-1705fe0a6cc9 30
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device, file e1dcb32e-156e-7715-e053-1705fe0a6cc9 9
Dosimetric analysis and experimental setup design for in-vivo irradiation with a Plasma Focus device, file e1dcb332-5595-7715-e053-1705fe0a6cc9 5
Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications, file e1dcb330-d91a-7715-e053-1705fe0a6cc9 4
null, file e1dcb330-1cbe-7715-e053-1705fe0a6cc9 3
Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status, file e1dcb330-4751-7715-e053-1705fe0a6cc9 2
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway., file e1dcb335-5756-7715-e053-1705fe0a6cc9 2
null, file e1dcb32c-097e-7715-e053-1705fe0a6cc9 1
null, file e1dcb338-82fb-7715-e053-1705fe0a6cc9 1
Totale 426
Categoria #
all - tutte 938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0010 10 00 0000
2019/202033 0100 52 33 3367
2020/202146 3931 23 35 5264
2021/2022197 15114 1213 1120 21146520
2022/2023146 5155832 711 162 0000
Totale 426